TUSCALMAN 2 G/0,1 G Syrop
Ocena recepty online
Lekarz przeanalizuje Twój przypadek i zdecyduje, czy wystawienie recepty jest medycznie uzasadnione.
Porozmawiaj z lekarzem o tym leku
Omów swoje objawy i opcje leczenia podczas szybkiej konsultacji online.
Jak stosować TUSKALMAN
Treść ulotki
- What is Coryfin Sedative Fluidifier and what is it used for
- What you need to know before using Coryfin Sedative Fluidifier
- How to use Coryfin Sedativo Fluidificante
- Possible side effects
- How to store Coryfin Sedativo Fluidificante
- Contents of the pack and other information
CORYFIN SEDATIVO FLUIDIFICANTE 20 mg/g + 1 mg/g syrup
potassium guaifenesinate + dextromethorphan hydrobromide
Read this leaflet carefully before using this medicine as it contains important
information for you.
Always use this medicine exactly as described in this leaflet or as your doctor or
pharmacist has told you to do.
- Keep this leaflet. You may need to read it again.
- If you want more information or advice, ask your pharmacist.
- If any side effects occur, including those not listed in this leaflet, tell your doctor or pharmacist. See section 4.
- See a doctor if you do not feel better or if your symptoms get worse after 7 days.
Contents of this leaflet:
- 1. What Coryfin Sedativo Fluidificante is and what it is used for
- 2. What you need to know before you use Coryfin Sedativo Fluidificante
- 3. How to use Coryfin Sedativo Fluidificante
- 4. Possible side effects
- 5. How to store Coryfin Sedativo Fluidificante
- 6. Contents of the pack and other information
1. What is Coryfin Sedative Fluidifier and what is it used for
Coryfin Sedative Fluidifier contains dextromethorphan hydrobromide, a cough suppressant, and
potassium guaifenesinate, an expectorant.
This medicine is indicated for the treatment of cough symptoms.
See your doctor if you do not feel better or if you feel worse after 7 days.
2. What you need to know before using Coryfin Sedative Fluidifier
This medicine can lead to dependence. Therefore, treatment should be of short
duration.
Do not use Coryfin Sedative Fluidifier
- if you are allergic to dextromethorphan or potassium guaifenesinate or any of the other ingredients of this medicine (listed in section 6);
- if you are taking or have taken up to 2 weeks ago antidepressants (medicines
- used for depression) (see “other medicines and Coryfin Sedative Fluidifier);
- if you suffer from asthma (narrowing and inflammation of the bronchi);
- if you have a respiratory disease characterized by bronchial obstruction and inflammation of the bronchi and lungs (chronic obstructive bronchopneumonia);
- if you have a lung infection (pneumonia);
- breathing problems (difficulty or depression of breathing);
- if you suffer from heart or blood vessel problems (cardiovascular diseases);
- if you have high blood pressure (hypertension);
- if you have an overactive thyroid (hyperthyroidism);
- if you suffer from a disease that causes increased pressure in the eye and vision problems (glaucoma);
- if you have an enlarged prostate (prostatic hypertrophy);
- if you have narrowing of the stomach or intestines (stenosis of the gastrointestinal tract);
- if you suffer from narrowing of the urinary or genital tract (stenosis of the urogenital tract);
- if you suffer from a disease that causes loss of consciousness and violent involuntary muscle contractions (epilepsy);
- if you have severe liver disease;
- if you are pregnant, especially in the first trimester, or are breastfeeding (see “Pregnancy and breastfeeding”);
- if the child to be treated is less than two years old.
Warnings and precautions
Consult your doctor or pharmacist before using Coryfin Sedative Fluidifier:
- if you have a history of drug or substance abuse (psychoactive substances capable of altering psycho-physical state);
- if the subject to be treated is an adolescent or young adult;
- if you have a chronic or persistent cough (due for example to smoking and some respiratory diseases such as emphysema / asthma);
- if the cough is accompanied by other symptoms such as fever, rash, headache, nausea and vomiting;
- if your cough is irritating with abundant mucus production;
- if you suffer from liver or kidney problems.
Other medicines and Coryfin Sedative Fluidifier
Tell your doctor or pharmacist if you are taking, have recently taken or may
take any other medicines.
Talk to your doctor or pharmacist before taking Coryfin Sedative Fluidifier if you are taking
medicines such as some antidepressants or antipsychotics: Coryfin Sedative Fluidifier
may interact with these medicines and changes in mental status (e.g.
agitation, hallucinations, coma) and other effects such as body temperature above 38° C,
increased heart rate, unstable blood pressure, exaggeration of reflexes, muscle rigidity,
lack of coordination and/or gastrointestinal symptoms (e.g. nausea, vomiting,
diarrhea) may occur.
Tell your doctor if you are being treated with:
- MAOIs, fluoxetine, paroxetine, sertraline and bupropion (medicines used to treat depression);
- methadone (a medicine used to treat severe pain or to reduce withdrawal symptoms in case of substance dependence);
- haloperidol, thioridazine, perphenazine (medicines used to treat mental disorders);
- amiodarone, flecainide, quinidine, propafenone (medicines used to treat heart rhythm disorders);
- cinacalcet (a medicine used to reduce the amount of calcium in the blood);
- terbinafine (a medicine used to treat fungal infections);
- linezolid (an antibiotic, a medicine used to treat bacterial infections);
- sibutramine (a medicine used to reduce appetite);
- sedatives (medicines that induce a state of unconsciousness);
- hypnotics (medicines used to treat insomnia);
- anxiolytics (medicines used to reduce anxiety). The concomitant use of Coryfin Sedative Fluidifier with sedatives such as benzodiazepines or similar medicines increases the risk of drowsiness, respiratory depression, coma and can be life-threatening. For this reason, concomitant use should only be considered when other treatment options are not possible. However, if the doctor prescribes Coryfin Sedative Fluidifier together with sedatives, the dose and duration of concomitant treatment must be limited by the doctor. Tell your doctor about all the sedatives you are taking and carefully follow their recommendations on dosage. It may be helpful to inform friends or family members so that they are aware of the signs and symptoms described above. If you experience these symptoms, contact your doctor. Coryfin Sedative Fluidifierwith alcoholIt is advisable not to drink alcohol during treatment with Coryfin Sedative Fluidifier.
Pregnancy and breastfeeding
If you are pregnant, suspect or are planning a pregnancy, or if you are breastfeeding
with breast milk, ask your doctor for advice before taking this medicine.
Coryfin Sedative Fluidifier should not be used during pregnancy, especially in the first
trimester, or during breastfeeding (see “Do not use Coryfin Sedative
Fluidifier”).
Driving and using machines
Coryfin Sedative Fluidifier can cause drowsiness, especially when combined
with the consumption of alcohol or other medicines that can reduce reaction times (see “Other
medicines and Coryfin Sedative Fluidifier”).
Avoiddriving, using machinery and performing other activities that require particular
attention
Coryfin Sedative Fluidifier contains:
- sucrose:if your doctor has diagnosed you with intolerance to certain sugars, contact him before taking this medicine. This medicine contains 6.8 g of sucrose per dose (2 measuring spoons = 20 ml, corresponding to the recommended dose for adolescents over 12 years of age). To be taken into consideration in people affected by diabetes mellitus. ethanol:This medicine contains 1.13 mg of alcohol (ethanol) in 20 ml. The amount in volume (20 ml) contained in this medicine is equivalent to less than 28 ml of beer or 11 ml of wine. The amount of alcohol in this medicine does not appear to have an effect on adults and adolescents and its effects in children are not evident. Some effects may occur in young children, for example feeling sleepy. The alcohol in this medicine may alter the effects of other medicines. Talk to your doctor or pharmacist if you are taking other medicines. If you are pregnant or breastfeeding, talk to your doctor or pharmacist before taking this medicine. If you have an alcohol dependence, talk to your doctor before taking this medicine.
- sodium methylparaben, sodium propylparaben:may cause allergic reactions (even delayed).
- sodium: this medicine contains less than 1 mmol (23 mg) of sodium per dose, i.e. essentially ‘sodium-free’.
Nie jesteś pewien, czy ten lek jest odpowiedni dla ciebie?
Omów swoje objawy i leczenie z lekarzem online.
3. How to use Coryfin Sedativo Fluidificante
Use this medicine following exactly as stated in this leaflet or as instructed by your doctor or pharmacist. If you have any doubts, consult your doctor or pharmacist.
The recommended dose is:
Adults and adolescents over 12 years
The recommended dose is 20 ml (corresponding to 2 measuring spoons of 10 ml), 1 to 3 times a day,
away from meals. The maximum daily dose is 60 ml. Do not exceed the recommended doses.
Children from 6 to 12 years
The recommended dose is 10 ml (corresponding to 1 measuring spoon of 10 ml), 1 to 3 times a day,
away from meals. The maximum daily dose is 30 ml. Do not exceed the recommended doses.
Children from 2 to 6 years
The recommended dose is 5 ml (corresponding to half a measuring spoon of 10 ml) 1 to 3 times a day,
away from meals.
The maximum daily dose is 15 ml. Do not exceed the recommended doses.
1 ml of syrup contains: 22.6 mg of potassium guaiacolsulfonate and 1.1 mg of dextromethorphan
bromhydrate.
Duration of treatment
Do not use Coryfin Sedativo Fluidificante for more than 7 days.
Consult your doctor if you do not notice any improvement or if your symptoms worsen after 7
days.
Instructions for use:
If you use more Coryfin Sedativo Fluidificante than you should
In case of ingestion/accidental intake of an excessive dose of Coryfin Sedativo
Fluidificante immediately notify your doctoror go to the nearest hospital.
Children
In children, in case of overdose, serious adverse events may occur, including neurological
disorders. Those caring for patients should not exceed the recommended dose.
If you take more Corifin Sedativo Fluidificante than you should, you may experience the following
symptoms: nausea and vomiting, involuntary muscle contractions, agitation, confusion, drowsiness,
cognitive disorders, involuntary and rapid eye movements, cardiac disorders (fast heartbeat), coordination disorders, psychosis with visual hallucinations and hyperexcitability.
Other symptoms in case of massive overdose may be: coma, severe breathing problems and
convulsions.
Contact your doctor or hospital immediately if you experience any of the aforementioned symptoms.
4. Possible side effects
Like all medicines, this medicine can cause side effects, although not everybody gets them.
With the use of this medicine, the following side effects may occur with
unknown frequency (frequency cannot be estimated based on available data):
- allergic reactions (hypersensitivity) including anaphylactic reaction (a severe allergic reaction with rapid onset and that can cause death), angioedema (swelling of the skin or mucous membranes), urticaria, itching, rash (skin eruptions) and erythema (redness of the skin);
- hallucinations (seeing or hearing things that do not exist);
- drowsiness, dizziness;
- gastrointestinal disorders (stomach and intestinal disorders), nausea, vomiting and loss of appetite
- fatigue, fever. Reporting of side effectsIf you experience any side effects, including those not listed in this leaflet, please inform your doctor or pharmacist. You can also report side effects directly through the national reporting system at https://www.aifa.gov.it/content/segnalazioni-reazioni-avverse By reporting side effects you can help provide more information on the safety of this medicine.
Zacząłeś przyjmować lek i masz pytania?
Omów swoje objawy i leczenie z lekarzem online.
5. How to store Coryfin Sedativo Fluidificante
Keep this medicine out of the sight and reach of children.
This medicine does not require any special storage conditions.
 | or To open the bottle: press the cap down while unscrewing in c an anticlockwise direction. a To close the bottle: screw the cap on tightly in a clockwise direction. m Use of the measuring device: to administer the recommended dose, pour the syrup into the measuring device until it reaches the mark corresponding to the dose. Wash the device after each use. |
Do not use this medicine after the expiry date stated on the pack after “Exp.”. The
expiry date refers to the last day of that month.
Do not dispose of any medicine in wastewater or household waste. Ask your pharmacist how to
dispose of medicines you no longer use. This will help protect the environment.
6. Contents of the pack and other information
What Coryfin Sedativo Fluidificante contains
The active ingredients are potassium guaifenesinate, dextromethorphan hydrobromide. 1 ml of syrup
contains: 22.6 mg of potassium guaifenesinate and 1.1 mg of dextromethorphan hydrobromide.
- The other ingredients are sucrose, ethanol, sodium chloride, sodium methylparahydroxybenzoate, ammonium glycyrrhizate, mint aroma, sodium propylparahydroxybenzoate, purified water.
Description of the appearance of Coryfin Sedativo Fluidificanteand contents of the pack
Coryfin Sedativo Fluidificante 20 mg/g + 1 mg/g syrup is available in a pack
containing an 180 g amber glass bottle with a child-resistant cap and graduated measuring cup.
Marketing Authorisation Holder
Laboratorio Farmaceutico SIT S.r.l. - Via Cavour, 70 - 27035 Mede (PV)
Manufacturer
Laboratorio Farmaceutico SIT S.r.l. - Via Provinciale per Lecco, 78 - 22038 Tavernerio (CO)
- Kraj rejestracji
- Postać farmaceutycznaSyrup, 2 G+0,1 G
- Kod ATCR05FA02
- Substancja czynna
- Wymaga receptyNie
- Producent
- Te treści mają charakter wyłącznie informacyjny i nie zastępują konsultacji lekarskiej.
- Zamienniki TUSKALMANPostać farmaceutyczna: Syrup, 1,5 MG/ML + 10 MG/MLSubstancja czynna: opium derivatives and expectorantsProducent: PERRIGO ITALIA S.R.L.Bez receptyPostać farmaceutyczna: Syrup, 0,144 G/100 ML + 2 G/100 MLSubstancja czynna: cough suppressants and expectorantsBez receptyPostać farmaceutyczna: Syrup, 1,2 G/100 ML + 0,1 G/100 MLSubstancja czynna: cough suppressants and expectorantsProducent: POLIFARMA BENESSERE S.R.L.Bez recepty
Odpowiedniki TUSKALMAN w innych krajach
Leki z tą samą substancją czynną dostępne w innych krajach.
Odpowiednik TUSKALMAN w Hiszpania
Odpowiednik TUSKALMAN w Ukraina
Lekarze online w sprawie TUSKALMAN
Omów stosowanie TUSKALMAN, bezpieczeństwo i ocenę zasadności recepty zgodnie z obowiązującymi przepisami.
Uzyskaj receptę na TUSKALMAN online
Wypełnij 2-minutowy formularz
Opisz swoje objawy, historię choroby i lek, o który prosisz.
Wybierz lekarza lub pozwól nam przydzielić
Wybierz specjalistę lub dopasujemy Cię do najbliższego dostępnego lekarza.
Lekarz analizuje Twój przypadek
Zazwyczaj w ciągu 30 minut. Może zadawać dodatkowe pytania przez czat.
Odbierz w dowolnej aptece
Recepta elektroniczna wysłana na Twój e-mail — ważna w całej Polsce.
Często zadawane pytania
TUSKALMAN nie wymaga recepty w Włochy. Możesz skonsultować się z lekarzem online, aby sprawdzić, czy ten lek może być odpowiedni w Twojej sytuacji.
Substancją czynną w TUSKALMAN jest opium derivatives and expectorants. Informacja ta pomaga rozpoznać leki o tym samym składzie, ale pod różnymi nazwami handlowymi.
TUSKALMAN jest produkowany przez LABORATORIO FARMACEUTICO SIT SPECIALITA IGIENICO TERAPEUTICHE S.R.L.. Nazwy handlowe i opakowania mogą się różnić w zależności od dystrybutora.
Lekarze, tacy jak Lekarze rodzinni, Psychiatrzy, Dermatolodzy, Kardiolodzy, Endokrynolodzy, Gastroenterolodzy, Pulmonolodzy, Nefrolodzy, Reumatolodzy, Hematolodzy, Zakaźnicy, Alergolodzy, Geriatrzy, Pediatrzy, Onkolodzy, mogą ocenić, czy stosowanie TUSKALMAN jest odpowiednie w Twoim przypadku, w zależności od sytuacji klinicznej i lokalnych przepisów. Możesz umówić konsultację online, aby omówić objawy i możliwe dalsze kroki.
Polska posiada dobrze rozwiniętą infrastrukturę ochrony zdrowia w dużych miastach, takich jak Warszawa, Kraków, Wrocław i Gdańsk. Apteki są łatwo dostępne i działają zgodnie z obowiązującymi przepisami, zapewniając dostęp do leków na receptę.
Możesz kupić TUSKALMAN w Warszawie, Krakowie, Wrocławiu lub Gdańsku w każdej aptece, posiadając ważną receptę.
Aby uzyskać receptę, możesz skorzystać z Oladoctor:
Inne leki zawierające tę samą substancję czynną (opium derivatives and expectorants) to m.in. BRONKENOLO SEDATIVO E FLUIDIFIKANTE, KORYFIN TOSSE DOPPIA ATSIONE, TIOKALMINA. Mogą one różnić się nazwą handlową lub postacią, ale zawierają ten sam składnik terapeutyczny. Przed zmianą lub rozpoczęciem nowego leku skonsultuj się z lekarzem.
